Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 15/20 | 0.65 |
| ▸ | PTGES | O14684 | 2/20 | 0.65 |
| ▸ | PNLIP | P16233 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.47 |
| ▸ | BCL9 | O00512 | 3/20 | 0.42 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | GSTO1 | P78417 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epiisorosmanol SCHEMBL29511557 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL12574307 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Isorosmanol SCHEMBL13294492 | 1.00 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL12969255 | 0.91 | FDPS (0.54) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL459610 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL3272202 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL28962181 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Epirosmanol SCHEMBL29426648 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| Rosmanol SCHEMBL13062163 | 0.84 | FDPS (0.65) | FDPSPTGESPNLIPMEN1KMT2A | |
| SCHEMBL4194868 | 0.82 | FDPS (0.59) | FDPSPTGESPNLIPMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | KIM DARRICK S H | 2007-01-04 | — | — | US | disclosed |
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | KIM DARRICK S H | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070003641-A1 | Synergistic pharmaceutical compositions useful in prevention and treatment of beta-amyloid protein-induced disease | APP, BACE1, GSAP | FDPS 2904/4885PTGES 197/4885PNLIP 3710/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.